- ►annals.org [PDF] MK Gould, AD Dembitzer, GD Sanders, AM … - Annals of internal medicine, 1999 - Am Coll Physicians Michael K. Gould, MD, MSc; Anne D. Dembitzer, MD; Gillian D. Sanders, PhD; and
Alan M. Garber, MD, PhD ... Background: Low-molecular-weight heparins are
effec- tive for treating venous thrombosis, but their cost- effectiveness ... Cited by 259 - Related articles - BL Direct - All 9 versions
- ►stjosham.on.ca [PDF] B O'Brien, M Levine, A Willan, R Goeree, S … - Archives of Internal Medicine, 1999 - Am Med Assoc Methods To conduct an economic evaluation we prospectively collected data on
resource use and health-related quality of life (Medical Outcomes Study
Short-Form 36) on the 300 patients who formed the trial stratum presenting ... Cited by 101 - Related articles - BL Direct - All 8 versions
- ►ecmaj.com [PDF] M Rodger, C Bredeson, PS Wells, J Beck, B … - Canadian Medical Association Journal, 1998 - ecmaj.com Contexte : La thrombose veineuse profonde aiguë a toujours été traitée au
moyen d'héparine non fractionnée (HNF) administrée par voie intraveineuse,
mais des héparines de faible poids moléculaire (HFPM), administrées par ... Cited by 57 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] MK Gould, AD Dembitzer, RL Doyle, TJ … - Annals of internal medicine, 1999 - Am Coll Physicians Michael K. Gould, MD, MSc; Anne D. Dembitzer, MD; Ramona L. Doyle, MD; Trevor J.
Hastie, PhD; and Alan M. Garber, MD, PhD ... Background: Low-molecular-weight
heparins may sim- plify the management of deep venous thrombosis. A criti- ... Cited by 441 - Related articles - BL Direct - All 4 versions
LR Dolovich, JS Ginsberg, JD Douketis, AM … - Archives of Internal Medicine, 2000 - Am Med Assoc Results Thirteen studies were included. There was no statistically significant
difference in risk between UFH and LMWHs for recurrent VTE (RR, 0.85 [95% CI,
0.65-1.12]), pulmonary embolism (RR, 1.02 [95% CI, 0.64-1.62]), major ... Cited by 393 - Related articles - BL Direct - All 5 versions
RD Hull, GE Raskob, D Rosenbloom, GF Pineo, … - Archives of Internal Medicine, 1997 - archinte.highwire.org Patients and Methods: A randomized trial in 432 pa- tients with proximal vein
thrombosis that compared in- travenous heparinand low-molecular-weight
heparinwith objective documentation of clinical outcomes provided the ... Cited by 122 - Related articles - BL Direct - All 4 versions
L Harrison, J McGinnis, M Crowther, J … - Archives of Internal Medicine, 1998 - Am Med Assoc Background Low-molecular-weight (LMW) heparins are safe and effective for
out-of-hospital treatment of acute deep-vein thrombosis (DVT) in a clinical
trial setting. We examined the efficacy, safety, and feasibility of home ... Cited by 183 - Related articles - BL Direct - All 4 versions
- ►lava.med.br [PDF] MMW Koopman, P Prandoni, F Piovella, PA … - The New England journal of medicine, 1996 - nejm.highwire.org Background An intravenous course of standard (unfractionated) heparin with the
dose adjusted to prolong the activated partial-thromboplastin time to a desired
length is the standard initial in-hospital treatment for patients with ... Cited by 780 - Related articles - BL Direct - All 12 versions
- ►timrodgersmd.com [PDF] M Levine, M Gent, J Hirsh, J Leclerc, D … - The New England journal of medicine, 1996 - nejm.highwire.org Results Thirteen of the 247 patients receiving low-molecular-weight heparin (5.3
percent) had recurrent thromboembolism, as compared with 17 of the 253 patients
receiving standard heparin (6.7 percent; P = 0.57; absolute difference, 1.4 ... Cited by 931 - Related articles - BL Direct - All 7 versions
AG Van den Belt, PM Bossuyt, MH Prins, AS … - Thrombosis and haemostasis, 1998 - ncbi.nlm.nih.gov Two clinical trials in patients with acute deep venous thrombosis have indicated
that the outpatient management with fixed-dose, subcutaneous
low-molecular-weight heparin is at least as effective and safe as inpatient ... Cited by 60 - Related articles - BL Direct - All 3 versions
